Phenomenal: Efficacy and safety of liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases Available

Authors
Category Primary study
ConferenceSan Antonio Breast Cancer Symposium 2024
Year 2025
This article has no abstract
Epistemonikos ID: 388cf6090bf2f08e0026366b5a65376159a4195d
First added on: Feb 16, 2026